50881-0013 MONJUVI - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

50881-0013

Brand Name:

MONJUVI

Generic Name:

Tafasitamab-cxix

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: TAFASITAMAB

Strength: 200.0

Unit: mg/5mL

Packages:

Code: 50881-0013-01

Description: 1 VIAL in 1 CARTON (50881-013-01) / 5 mL in 1 VIAL

Effective Date: Aug. 5, 2020

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

CD19

Orphan Drug Designation:

Status:

In Use